Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.

about

Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.

Item

http://www.wikidata.org/entity/Q38136078

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Individualized therapy for hep ...... morphism in directing therapy.

@en

type

Item

label

Individualized therapy for hep ...... morphism in directing therapy.

@en

prefLabel

Individualized therapy for hep ...... morphism in directing therapy.

@en

P1476

Individualized therapy for hep ...... morphism in directing therapy.

@en

P2093

Hans L Tillmann

http://www.w3.org/2001/XMLSchema#string

Keyur Patel

http://www.w3.org/2001/XMLSchema#string

Tzu-Hao Lee

http://www.w3.org/2001/XMLSchema#string

P2860

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Boceprevir for previously treated chronic HCV genotype 1 infection

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication

Lambda interferon inhibits hepatitis B and C virus replication.

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

P2888

s40291-013-0053-4

P304

25-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40291-013-0053-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047912989

http://www.w3.org/2001/XMLSchema#string

P698

24022240

http://www.w3.org/2001/XMLSchema#string